0.00(0%)

Last update at

Day Range

LowHigh

52 Week Range

LowHigh

Fundamentals

Previous Close -
Market Cap-
Volume
P/E Ratio-
Dividend Yield-%
Revenue TTM-
Revenue Per Share TTM-
Gross Profit TTM -
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now?
Tue 13 May 25, 12:54 PM
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?
Wed 16 Apr 25, 02:15 PM
Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple
Wed 09 Apr 25, 02:55 PM
Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Thu 03 Apr 25, 11:00 AM
High Growth Tech Stocks To Watch In The US April 2025
Tue 01 Apr 25, 11:08 AM
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now?
Wed 26 Mar 25, 02:40 PM
Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory
Wed 05 Mar 25, 02:03 PM
When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit?
Sun 02 Mar 25, 12:01 PM
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
Fri 28 Feb 25, 06:26 PM
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
Thu 27 Feb 25, 09:01 PM

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown

Breakdown

Breakdown

Peer Comparison

Sector: Industry:

Company	Change ()	Price ()	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.